hydroxyproline has been researched along with daunorubicin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wiedemann, P | 1 |
| Koide, H; Ohno, J; Soeda, N | 1 |
| Adamcová, M; Aupperle, H; Geršl, V; Mazurová, Y; Popelová, O; Potáčová, A; Štěrba, M | 1 |
1 review(s) available for hydroxyproline and daunorubicin
| Article | Year |
|---|---|
[Drug treatment of proliferative vitreoretinopathy].
Topics: Blood-Retinal Barrier; Colchicine; Daunorubicin; Fluorouracil; Heparin; Humans; Hydroxyproline; Isomerism; Penicillamine; Retinal Degeneration; Steroids; Vitreous Body | 1989 |
2 other study(ies) available for hydroxyproline and daunorubicin
| Article | Year |
|---|---|
Biochemical properties of glomerular basement membrane in daunomycin nephrosis and nephrotoxic serum nephritis.
Topics: Animals; Basement Membrane; Carbohydrates; Cysteine; Daunorubicin; Glomerulonephritis; Glycine; Hydroxylysine; Hydroxyproline; Kidney Glomerulus; Nephrosis; Rats | 1981 |
Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiovascular Agents; Chronic Disease; Collagen; Daunorubicin; Disease Models, Animal; Drug Interactions; Fibrosis; Hydroxyproline; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardium; Rabbits; Razoxane; Ventricular Remodeling | 2010 |